[18f]-Fdg-Fzk Zag Zyklotron

Fludeoxyglucose (18F) is a radiopharmaceutical used in PET scans for metabolic imaging. It helps visualize glucose metabolism in tissues. This product is intended for intravenous administration only. Always consult a healthcare professional for proper use.

Fludeoxyglucose (18F) is primarily used in positron emission tomography (PET) scans to assess metabolic activity in the body. It is commonly used in oncology for detecting cancer, cardiology for evaluating heart conditions, and neurology for brain imaging. The drug helps identify areas of abnormal metabolic activity, aiding in diagnosis and treatment planning.

After intravenous injection, Fludeoxyglucose (18F) distributes throughout the body and accumulates in tissues with high metabolic rates. It emits positrons that are detected by the PET scanner, creating detailed images of metabolic processes. The effects are temporary and localized to the imaging procedure.

Fludeoxyglucose (18F) should only be handled and administered by trained professionals. Patients should avoid strenuous activity before the scan and follow fasting guidelines as directed. Pregnant or breastfeeding individuals should inform their healthcare provider before use. Proper hydration is recommended post-administration.

No significant drug interactions are reported with Fludeoxyglucose (18F) itself. However, medications affecting glucose metabolism, such as insulin or oral hypoglycemics, may influence imaging results. Alcohol and caffeine should be avoided before the scan. Always disclose all medications to the healthcare provider.